IPO Subscription Today (10 Aug 2026): Technocraft Leads at 3x, Dhoot and Molbio Open
IPO Market Update | 10 August 2026
IPO Subscription Today: Five Issues Open for Investors
Investors tracking the IPO subscription status today, 10 August 2026, have five active issues to watch across the mainboard and SME segments. Subscription trends remain mixed, with Technocraft Ventures Limited emerging as the strongest subscribed issue at 3.00x, while Dhoot Transmission, Molbio Diagnostics and Leap India are still below full subscription.
The current subscription data provides an early indication of investor demand, but investors should remember that subscription levels can change significantly before an IPO closes.
IPO Subscription Status Today
Technocraft Ventures IPO Leads Subscription Race at 3x
Technocraft Ventures Limited is currently the strongest subscribed IPO among the five active issues. The IPO opened on 7 August and closes on 11 August 2026. It has received bids for 2,49,14,190 shares against 83,17,190 shares offered, taking total subscription to 3.00x.
The strong demand makes Technocraft Ventures the key IPO to watch as the issue approaches its closing date. However, investors should look beyond subscription multiples and evaluate the company's financial performance, valuation and business outlook before making an investment decision.
Optimystix Entertainment Subscription Reaches 0.72x
Optimystix Entertainment India Limited, an SME IPO, has recorded subscription of 0.72x. The issue opened on 7 August and closes on 11 August. Against 45,29,600 shares offered, investors have bid for 32,58,400 shares.
With the issue still open, the subscription level could move higher before the closing date. Investors should also consider the additional risks and liquidity considerations associated with SME-listed stocks.
Dhoot Transmission IPO Opens at 0.28x
Dhoot Transmission Limited opened for subscription on 10 August 2026 and has received bids for 69,23,675 shares against an offer size of 2,49,56,363 shares. The issue is currently subscribed 0.28x.
The IPO remains open until 12 August, giving investors additional time to participate. The relatively low subscription level on the opening day does not represent the final demand for the issue, as subscription activity can accelerate during the final days.
Molbio Diagnostics IPO at 0.24x Subscription
Molbio Diagnostics Limited also opened on 10 August and has recorded subscription of 0.24x so far. Investors have bid for 19,64,520 shares compared with 81,58,529 shares offered.
The issue closes on 12 August 2026. Investors tracking the Molbio Diagnostics IPO subscription status should monitor changes in demand during the remaining subscription period rather than relying solely on the first-day figure.
Leap India IPO Trails at 0.16x
Leap India Limited currently has the lowest subscription level among the five IPOs at 0.16x. The issue opened on 7 August and closes on 11 August 2026.
The company has offered 11,49,91,735 shares, while bids have been received for 1,85,82,954 shares so far. With the closing date approaching, investors will be watching whether subscription demand improves before the issue closes.
Which IPO Has the Highest Subscription Today?
Based on the subscription figures provided for 10 August 2026, Technocraft Ventures Limited leads the list at 3.00x. Optimystix Entertainment follows at 0.72x, while Dhoot Transmission, Molbio Diagnostics and Leap India remain below 1x subscription.
Subscription data shows investor demand at a particular point in time. It should not be treated as a direct indicator of listing gains or future stock performance. Always consider valuation, financials, industry outlook, risks and your own investment objectives before applying for an IPO.
Track Live IPO Subscription Updates
For investors who want to monitor IPO subscription numbers, issue details and upcoming offerings in one place, visit the StockMunch IPO Desk.
Disclaimer: IPO subscription figures can change throughout the day and may differ across investor categories. This article is for informational purposes only and should not be considered investment advice.